AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35732382 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured psychiatric interviews and self‐rated symptom severity scales
Number of subjects: 480
Study 35732382 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐rated Stress‐Induced Exhaustion Disorder (SED) Instrument (s‐ED)
Number of subjects: 480
Study 35732382 — intervention group
Group type: EXPERIMENTAL
Intervention: Montgomery‐Asberg Depression Rating Scale‐self‐rating version and the Karolinska Exhaustion Disorder Scale
Number of subjects: 480
Study 35860019 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 IU/day of cholecalciferol for 14 days
Number of subjects: 85
Study 35860019 — intervention group
Group type: COMPARATOR
Intervention: 2,000 IU/day of cholecalciferol for 14 days
Number of subjects: 85
Study 34148764 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention program (curriculum)
Number of subjects: 255
Study 32087126 — intervention group
Group type: EXPERIMENTAL
Intervention: Emollient group (Diprobase cream or DoubleBase gel) with standard skin-care advice
Number of subjects: 1394
Study 32087126 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard skin-care advice only)
Number of subjects: 1394
Study 32087126 — intervention group
Group type: EXPERIMENTAL
Intervention: Emollient group
Number of subjects: 1394
Study 32087126 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1394
Study 35316819 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection into the right splenius capitis muscle
Number of subjects: 40
Study 35316819 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 40
Study 35316819 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection
Number of subjects: 40
Study 34610257 — intervention group
Group type: EXPERIMENTAL
Intervention: BAK-containing latanoprost (Xalatan)
Number of subjects: 150
Study 34610257 — intervention group
Group type: COMPARATOR
Intervention: Preservative-free bimatoprost (Lumigan PF)
Number of subjects: 150
Study 32297946 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-enabled health monitoring devices (4 devices: weight scale, BP monitor, rhythm monitor, step counter) with 2 electronic visits replacing in-person visits.
Number of subjects: 200
Study 32297946 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-enabled health monitoring devices
Number of subjects: 200
Study 32297946 — intervention group
Group type: COMPARATOR
Intervention: Regular care (4 physical outpatient clinic visits scheduled in the year following the initial event).
Number of subjects: 200
Study 32297946 — intervention group
Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 200
Study 34547217 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum neurotoxin A therapy (BoNT‐A) with intensive rehabilitation
Number of subjects: 139
Study 34547217 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 139
Study 32321717 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxane treatment (docetaxel)
Number of subjects: 0
Study 32321717 — intervention group
Group type: COMPARATOR
Intervention: Taxane-sensitive cell lines
Number of subjects: 0
Study 32321717 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel treatment
Number of subjects: 0
Study 33779376 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 104
Study 33779376 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine
Number of subjects: 104
Study 33779376 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine and Hydrocortisone
Number of subjects: 104
Study 33779376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 34915104 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic (16 g inulin)
Number of subjects: 16
Study 34915104 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus paracasei subsp. paracasei 431)
Number of subjects: 16
Study 34915104 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic (combination of prebiotic and probiotic)
Number of subjects: 16
Study 34915104 — intervention group
Group type: COMPARATOR
Intervention: Control (16 g maltodextrin)
Number of subjects: 16
Study 34915104 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic (21 days consumption)
Number of subjects: 16
Study 34915104 — intervention group
Group type: COMPARATOR
Intervention: Control (21 days consumption)
Number of subjects: 16
Study 33497643 — intervention group
Group type: EXPERIMENTAL
Intervention: CEH-EUS
Number of subjects: 240
Study 33497643 — intervention group
Group type: COMPARATOR
Intervention: Conventional EUS
Number of subjects: 240
Study 35783144 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Quan (60-min classes, three times per week for 12 weeks)
Number of subjects: 138
Study 35783144 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (10 min of evaluation and warm-up, 40 min of therapist-directed exercise therapy, and 10 min of relaxation, three times per week for 12 weeks)
Number of subjects: 138
Study 35783144 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Quan
Number of subjects: 138
Study 35783144 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 138
Study 33443588 — intervention group
Group type: EXPERIMENTAL
Intervention: Nipple shield use in pain group (PG)
Number of subjects: 48
Study 33443588 — intervention group
Group type: COMPARATOR
Intervention: Nipple shield use in comparison group (CG)
Number of subjects: 48
Study 34325499 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surfactant therapy (MIST)
Number of subjects: 112
Study 34325499 — intervention group
Group type: COMPARATOR
Intervention: INSURE technique
Number of subjects: 112
Study 33340113 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed method with contextualized word embedding and multilayer perceptron
Number of subjects: 0
Study 33340113 — intervention group
Group type: COMPARATOR
Intervention: Stanford NER tagger
Number of subjects: 0
Study 33802268 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-day bathing cycle
Number of subjects: 32
Study 33802268 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-day bathing cycle
Number of subjects: 32
Study 33802268 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 32
Study 33175490 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model based on crystal graph convolutional neural networks for predicting methane adsorption properties.
Number of subjects: 11000
Study 33175490 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchical screening of hypothetical MOFs database.
Number of subjects: 11000
Study 33175490 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated maximum working capacity of hypothetical MOF.
Number of subjects: 11000
Study 34711060 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet injection with a slot-shaped nozzle
Number of subjects: 20
Study 34711060 — intervention group
Group type: COMPARATOR
Intervention: Lancet prick
Number of subjects: 20
Study 34711060 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet injection with differently shaped nozzles
Number of subjects: 20
Study 32611274 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposed K-wire fixation
Number of subjects: 220
Study 32611274 — intervention group
Group type: COMPARATOR
Intervention: Buried K-wire fixation
Number of subjects: 220
Study 36098249 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-tailored communication (messaging based on CDC's seasonal influenza vaccination campaign)
Number of subjects: 0
Study 36098249 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored communication (comprehensive communication including reinforcement of the importance of influenza vaccination for high-risk individuals)
Number of subjects: 0
Study 36098249 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care control
Number of subjects: 0
Study 36098249 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey results (unvaccinated respondents)
Number of subjects: 0
Study 32738891 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalational anesthesia (group I): Induced with propofol (1-2 mg/kg) and rocuronium (0.6-1 mg/kg), maintained with 1-2 vol% sevoflurane, 0.01-0.2 μg/kg/min remifentanil, and O2/air (FiO2 0.4).
Number of subjects: 0
Study 32738891 — intervention group
Group type: COMPARATOR
Intervention: Total Intravenous Anesthesia (TIVA) (group T): Induced with propofol (3-6 μg/mL), remifentanil (2-6 ng/mL), and rocuronium (0.6-1 mg/kg) using target controlled infusion (TCI).
Number of subjects: 0
Study 35833889 — intervention group
Group type: EXPERIMENTAL
Intervention: Germinated brown rice (GBR), 100 g per day for 12 weeks
Number of subjects: 99
Study 35833889 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular diet)
Number of subjects: 99
Study 34480127 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 594
Study 34480127 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 594
Study 32513125 — intervention group
Group type: EXPERIMENTAL
Intervention: Slit‐scanning topography (SST)
Number of subjects: 96
Study 32513125 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic pachymetry (UP)
Number of subjects: 96
Study 32513125 — intervention group
Group type: COMPARATOR
Intervention: Optical coherence tomography (OCT)
Number of subjects: 96
Study 36266474 — intervention group
Group type: EXPERIMENTAL
Intervention: Light/Darkness Cycle (LDC) - light from 07:00 to 19:00 and darkness (25 lx) from 19:00 to 07:00
Number of subjects: 294
Study 36266474 — intervention group
Group type: COMPARATOR
Intervention: Continuous Bright Light (CBL) - normal room light conditions 24 hours a day
Number of subjects: 294
Study 34061695 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated stress inoculation training (SIT) and exercise
Number of subjects: 53
Study 34061695 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 53
Study 32648022 — intervention group
Group type: COMPARATOR
Intervention: 600 mg NZBC extract prior to a high-carbohydrate, high-fat liquid meal (n=12)
Number of subjects: 25
Study 32648022 — intervention group
Group type: COMPARATOR
Intervention: 8-days supplementation with NZBC extract (600 mg day-1) (n=13)
Number of subjects: 25
Study 32666739 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomofix plate (locking steel plate)
Number of subjects: 0
Study 32666739 — intervention group
Group type: EXPERIMENTAL
Intervention: No bone graft
Number of subjects: 0
Study 32666739 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone graft
Number of subjects: 0
Study 32666739 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic bone graft (fragmented cancellous or wedge-shaped cancellous bone)
Number of subjects: 0
Study 32666739 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-phosphorus bone substitute material
Number of subjects: 0
Study 32666739 — intervention group
Group type: EXPERIMENTAL
Intervention: Augment factors
Number of subjects: 0
Study 33399381 — intervention group
Group type: EXPERIMENTAL
Intervention: Reference listed ropivacaine (NaropinTM)
Number of subjects: 18
Study 33399381 — intervention group
Group type: COMPARATOR
Intervention: Generic preparation of ropivacaine
Number of subjects: 18
Study 32318864 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudomonas strains (6 selected strains)
Number of subjects: 17
Study 32318864 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudomonas acidovorans 2R
Number of subjects: 17
Study 32318864 — intervention group
Group type: EXPERIMENTAL
Intervention: All Pseudomonas strains
Number of subjects: 17
Study 32318864 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudomonas aeruginosa 98.5 and Pseudomonas fluorescens 97.4
Number of subjects: 17
Study 34240572 — intervention group
Group type: EXPERIMENTAL
Intervention: Allisartan Isoproxil (AI) single dose of 480 mg
Number of subjects: 12
Study 34240572 — intervention group
Group type: EXPERIMENTAL
Intervention: Allisartan Isoproxil (AI) multiple doses of 480 mg once daily for 7 days
Number of subjects: 12
Study 34240572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 34420828 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse home visiting
Number of subjects: 1138
Study 34420828 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1138
Study 35836287 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health nursing interventions plus m-Health applications
Number of subjects: 120
Study 35836287 — intervention group
Group type: COMPARATOR
Intervention: m-Health applications alone
Number of subjects: 120
Study 35836287 — intervention group
Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 120
Study 35667771 — intervention group
Group type: EXPERIMENTAL
Intervention: dual‐tDCS with anodal over the lesioned hemisphere M1 and cathodal over the nonlesioned hemisphere, at 2 mA for 20 min before training for five consecutive days
Number of subjects: 25
Study 35667771 — intervention group
Group type: COMPARATOR
Intervention: sham tDCS before training
Number of subjects: 25
Study 35406139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol (15 mg/day)
Number of subjects: 29
Study 35406139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol (5 mg/day)
Number of subjects: 29
Study 35406139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 34245349 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashtanga-Yoga three times a week for 3 months
Number of subjects: 83
Study 34245349 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashtanga-Yoga
Number of subjects: 83
Study 34245349 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 83
Study 32606635 — intervention group
Group type: EXPERIMENTAL
Intervention: R0.2% ropivacaine
Number of subjects: 120
Study 32606635 — intervention group
Group type: EXPERIMENTAL
Intervention: R0.3% ropivacaine
Number of subjects: 120
Study 32606635 — intervention group
Group type: EXPERIMENTAL
Intervention: R0.4% ropivacaine
Number of subjects: 120
Study 32606635 — intervention group
Group type: COMPARATOR
Intervention: Control group without PECS II Block
Number of subjects: 120
Study 34203286 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Creatine and Sodium Bicarbonate (CSB) supplementation (20 g/day creatine and 0.3 g/kg/day sodium bicarbonate, taken four times a day for seven days)
Number of subjects: 20
Study 34203286 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Creatine and Sodium Bicarbonate (CSB) supplementation
Number of subjects: 20
Study 34203286 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 20
Study 32375847 — intervention group
Group type: EXPERIMENTAL
Intervention: Emsold metatarsal dome positioned 5 mm proximal to the metatarsal heads
Number of subjects: 36
Study 32375847 — intervention group
Group type: EXPERIMENTAL
Intervention: Langer PPT metatarsal pad positioned 5 mm proximal to the metatarsal heads
Number of subjects: 36
Study 32375847 — intervention group
Group type: COMPARATOR
Intervention: Control (no pad) condition
Number of subjects: 36
Study 32375847 — intervention group
Group type: EXPERIMENTAL
Intervention: Emsold metatarsal dome positioned in-line with the metatarsal heads
Number of subjects: 36
Study 32375847 — intervention group
Group type: EXPERIMENTAL
Intervention: Emsold metatarsal dome positioned 5 mm distal to the metatarsal heads
Number of subjects: 36
Study 32375847 — intervention group
Group type: EXPERIMENTAL
Intervention: Langer PPT metatarsal pad positioned in-line with the metatarsal heads
Number of subjects: 36
Study 32375847 — intervention group
Group type: EXPERIMENTAL
Intervention: Langer PPT metatarsal pad positioned 5 mm distal to the metatarsal heads
Number of subjects: 36
Study 32627231 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent integrative intervention (cognitive training, dietary instruction, physical activity, management of vascular risk factors)
Number of subjects: 96
Study 32627231 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent integrative intervention
Number of subjects: 96
Study 32627231 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study 33808526 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai-Chi training (TC)
Number of subjects: 80
Study 33808526 — intervention group
Group type: COMPARATOR
Intervention: Health education sessions (HE)
Number of subjects: 80
Study 32107012 — intervention group
Group type: EXPERIMENTAL
Intervention: VR + CL
Number of subjects: 11
Study 32107012 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 11
Study 32107012 — intervention group
Group type: EXPERIMENTAL
Intervention: VR
Number of subjects: 11
Study 36002178 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music (Sonata for Two Pianos in D Major, K.448)
Number of subjects: 121
Study 36002178 — intervention group
Group type: COMPARATOR
Intervention: White noise
Number of subjects: 121
Study 34479673 — intervention group
Group type: EXPERIMENTAL
Intervention: PRF + OFD
Number of subjects: 90
Study 34479673 — intervention group
Group type: EXPERIMENTAL
Intervention: GTR
Number of subjects: 90
Study 34479673 — intervention group
Group type: COMPARATOR
Intervention: OFD alone
Number of subjects: 90
Study 33851329 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg Cr(VI)
Number of subjects: 32
Study 33851329 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg Cr(VI)
Number of subjects: 32
Study 33851329 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/kg Cr(VI)
Number of subjects: 32
Study 33851329 — intervention group
Group type: COMPARATOR
Intervention: Control (0 mg/kg Cr(VI))
Number of subjects: 32
Study 33992542 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of oxaliplatin-based chemotherapy
Number of subjects: 6065
Study 33992542 — intervention group
Group type: COMPARATOR
Intervention: 6 months of oxaliplatin-based chemotherapy
Number of subjects: 6065
Study 35871058 — intervention group
Group type: EXPERIMENTAL
Intervention: MND-2119 2 g/day
Number of subjects: 580
Study 35871058 — intervention group
Group type: EXPERIMENTAL
Intervention: MND-2119 4 g/day
Number of subjects: 580
Study 35871058 — intervention group
Group type: COMPARATOR
Intervention: EPA-E 1.8 g/day
Number of subjects: 580
Study 35871058 — intervention group
Group type: COMPARATOR
Intervention: EPA-E 2.7 g/day
Number of subjects: 580
Study 33298604 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol Target-Controlled Infusion (TCI)
Number of subjects: 25
Study 35978074 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (5% NaF) with professional cleaning every 4 weeks
Number of subjects: 150
Study 35978074 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone therapy before varnishing (Groups II and IV)
Number of subjects: 150
Study 35978074 — intervention group
Group type: EXPERIMENTAL
Intervention: Octenidine mouthrinse (Groups III and IV)
Number of subjects: 150
Study 35978074 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group K) with no professional hygienic or prophylactic procedures
Number of subjects: 150
Study 33130104 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g gluten/d for 14 days
Number of subjects: 14
Study 33130104 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g gluten/d for 14 days
Number of subjects: 14
Study 32719231 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 209
Study 32719231 — intervention group
Group type: EXPERIMENTAL
Intervention: KTP laser
Number of subjects: 209
Study 32719231 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 209
Study 35115180 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 295
Study 35115180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 295
Study 35800292 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (DB group; 120 mg once every 4 weeks with loading doses of 120 mg on days 8 and 15; n = 80)
Number of subjects: 160
Study 35800292 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic acid (ZA group; 4 mg once every 4 weeks; n = 80)
Number of subjects: 160
Study 35800292 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (DB group)
Number of subjects: 160
Study 35800292 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic acid (ZA group)
Number of subjects: 160
Study 33890144 — intervention group
Group type: COMPARATOR
Intervention: Group 60 (SWL frequency: 60 SWs/min)
Number of subjects: 71
Study 33890144 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 90 (SWL frequency: 90 SWs/min)
Number of subjects: 71
Study 33054934 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandwagon-based statement (N=80)
Number of subjects: 400
Study 33054934 — intervention group
Group type: EXPERIMENTAL
Intervention: Testimonial-based statement (N=80)
Number of subjects: 400
Study 33054934 — intervention group
Group type: COMPARATOR
Intervention: Positive framing (N=80)
Number of subjects: 400
Study 33054934 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative framing (N=80)
Number of subjects: 400
Study 33054934 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparative advertising (N=80)
Number of subjects: 400
Study 36233606 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing algorithmic music
Number of subjects: 22
Study 36233606 — intervention group
Group type: COMPARATOR
Intervention: Activating algorithmic music
Number of subjects: 22
Study 32993338 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid (CS) in periarticular injection
Number of subjects: 187
Study 32993338 — intervention group
Group type: COMPARATOR
Intervention: No corticosteroid (no-CS) in periarticular injection
Number of subjects: 187
Study 36192738 — intervention group
Group type: EXPERIMENTAL
Intervention: Home stretching exercises with spinal manipulative therapy
Number of subjects: 127
Study 36192738 — intervention group
Group type: COMPARATOR
Intervention: Home stretching exercises alone
Number of subjects: 127
Study 32981083 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention program (8-week duration)
Number of subjects: 79
Study 32981083 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 79
Study 32583567 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy (arm A)
Number of subjects: 749
Study 32583567 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative S‐1 plus oxaliplatin (SOX, arm B)
Number of subjects: 749